MétaCan
Menu
Back to cohort
Record W2018046598 · doi:10.1093/jnci/djv081

Identification of Novel Genetic Markers of Breast Cancer Survival

2015· review· en· W2018046598 on OpenAlexaff
Qi Guo, Marjanka K. Schmidt, Peter Kraft, Sander Canisius, Constance Chen, Sofia Khan, Jonathan P. Tyrer, Manjeet K. Bolla, Qin Wang, Joe Dennis, Kyriaki Michailidou, Michael Lush, Siddhartha Kar, Jonathan Beesley, Alison M. Dunning, Mitul Shah, Kamila Czene, Hatef Darabi, Mikael Eriksson, Diether Lambrechts, Caroline Weltens, Karin Leunen, Stig E. Bojesen, Børge G. Nordestgaard, Sune F. Nielsen, Henrik Flyger, Jenny Chang‐Claude, Anja Rudolph, Petra Seibold, Dieter Flesch‐Janys, Carl Blomqvist, Kristiina Aittomäki, Rainer Fagerholm, Taru Muranen, Fergus J. Couch, Janet E. Olson, Celine M. Vachon, Irene L. Andrulis, Julia A. Knight, Gord Glendon, Anna Marie Mulligan, Annegien Broeks, Frans B.L. Hogervorst, Christopher A. Haiman, Brian E. Henderson, Fredrick R. Schumacher, Loı̈c Le Marchand, John L. Hopper, Helen Tsimiklis, Carmel Apicella, Melissa C. Southey, Angela Cox, Simon S. Cross, Malcolm Reed, Graham G. Giles, Roger L. Milne, Catriona McLean, Robert Winqvist, Katri Pylkäs, Arja Jukkola‐Vuorinen, Mervi Grip, Maartje J. Hooning, Antoinette Hollestelle, John W.M. Martens, Ans M.W. van den Ouweland, F. Marmé, Andreas Schneeweiß, Rongxi Yang, Barbara Burwinkel, Jonine D. Figueroa, Stephen J. Chanock, Jolanta Lissowska, Elinor J. Sawyer, Ian Tomlinson, Michael J. Kerin, Nicola Miller, Hermann Brenner, Aida Karina Dieffenbach, Volker Arndt, Bernd Holleczek, Vesa Kataja, Veli‐Matti Kosma, Jaana M. Hartikainen, Jingmei Li, Judith S. Brand, Keith Humphreys, Peter Devilee, Rob A.�E.�M. Tollenaar, Caroline Seynaeve, Paolo Radice, Paolo Peterlongo, Bernardo Bonanni, P. Mariani, Peter A. Fasching, Matthias W. Beckmann, Alexander Hein, Arif B. Ekici, Georgia Chenevix‐Trench, Rosemary L. Balleine, Kelly‐Anne Phillips, Javier Benı́tez, M. Pilar Zamora, José Ignacio Arias Pérez, Primitiva Menéndez, Anna Jakubowska, Jan Lubiński, Katarzyna Jaworska–Bieniek, Katarzyna Durda, Ute Hamann, Maria Kabisch, Hans Ulrich Ulmer, Thomas Rüdiger, Sara Margolin, Vessela N. Kristensen, Silje Nord, D. Gareth Evans, Jean Abraham, Helena Earl, Louise Hiller, Janet Dunn, S. Bowden, Christine D. Berg, Daniele Campa, W. Ryan Diver, Susan M. Gapstur, Mia M. Gaudet, Susan E. Hankinson, Robert N. Hoover, Anika Hüsing, Rudolf Kaaks, Mitchell J. Machiela, Walter C. Willett, Myrto Barrdahl, Federico Canzian, Suet‐Feung Chin, Carlos Caldas, David J. Hunter, Sara Lindström, Montserrat García‐Closas, Per Hall, Douglas F. Easton, Nazneen Rahman, Heli Nevanlinna, Paul D.P. Pharoah

Bibliographic record

VenueJNCI Journal of the National Cancer Institute · 2015
Typereview
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsUniversity Health NetworkCancer Care OntarioUniversity of Toronto
FundersNational Cancer InstituteFonds Wetenschappelijk OnderzoekCancer Institute NSWNational Institute for Health and Care ResearchNational Institutes of HealthNational Health and Medical Research CouncilCancer Research UKNederlandse Organisatie voor Wetenschappelijk OnderzoekNational Breast Cancer FoundationFrancis Crick InstituteEuropean CommissionMedical Research CouncilL'Oreal USA
KeywordsIdentification (biology)Breast cancerComputational biologyCancerBiologyOncologyGenetic markerMedicineGeneticsGene

Abstract

fetched live from OpenAlex

BACKGROUND: Survival after a diagnosis of breast cancer varies considerably between patients, and some of this variation may be because of germline genetic variation. We aimed to identify genetic markers associated with breast cancer-specific survival. METHODS: We conducted a large meta-analysis of studies in populations of European ancestry, including 37954 patients with 2900 deaths from breast cancer. Each study had been genotyped for between 200000 and 900000 single nucleotide polymorphisms (SNPs) across the genome; genotypes for nine million common variants were imputed using a common reference panel from the 1000 Genomes Project. We also carried out subtype-specific analyses based on 6881 estrogen receptor (ER)-negative patients (920 events) and 23059 ER-positive patients (1333 events). All statistical tests were two-sided. RESULTS: We identified one new locus (rs2059614 at 11q24.2) associated with survival in ER-negative breast cancer cases (hazard ratio [HR] = 1.95, 95% confidence interval [CI] = 1.55 to 2.47, P = 1.91 x 10(-8)). Genotyping a subset of 2113 case patients, of which 300 were ER negative, provided supporting evidence for the quality of the imputation. The association in this set of case patients was stronger for the observed genotypes than for the imputed genotypes. A second locus (rs148760487 at 2q24.2) was associated at genome-wide statistical significance in initial analyses; the association was similar in ER-positive and ER-negative case patients. Here the results of genotyping suggested that the finding was less robust. CONCLUSIONS: This is currently the largest study investigating genetic variation associated with breast cancer survival. Our results have potential clinical implications, as they confirm that germline genotype can provide prognostic information in addition to standard tumor prognostic factors.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.951
Threshold uncertainty score0.998

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.101
GPT teacher head0.403
Teacher spread0.302 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations244
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueJNCI Journal of the National Cancer InstituteSame topicBRCA gene mutations in cancerFrench-language works237,207